ML19325E112
Text
J. Barrett UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. John Barrett, Chairman Citizen Potawatomi Nation 1601 S. Gordon Cooper Dr.
Shawnee, OK 74801
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Barrett:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
J. Barrett 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Citizen Potawatomi Nation under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
J. Barrett 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Kelli Mosteller, THPO
J. Barrett UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Mike Wiggins, Jr, Chairman Bad River Band of Lake Superior Chippewa Indians P.O. Box 39 Odanah, WI 54861
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Wiggins:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
M. Wiggins 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Bad River Band of Lake Superior Chippewa Indians under NHPA.
Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
M. Wiggins 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Ms. Edith Leoso, THPO
L. Taylor UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Lewis Taylor, Chairman St. Croix Chippewa Indians of Wisconsin St. Croix Tribal Center 24663 Angeline Ave.
Webster, WI 54893
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Taylor:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
L. Taylor 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the St. Croix Chippewa Indians of Wisconsin under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
L. Taylor 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Ms. Wanda McFaggan, THPO
D. Cox UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Douglas Cox, Chairman Menominee Indian Tribe of Wisconsin W2908 Tribal Office Loop Road P.O. Box 910 Keshena, WI 54135
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Cox:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
D. Cox 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Menominee Indian Tribe of Wisconsin under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
D. Cox 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. David Grignon, THPO
D.Cox UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Anthony Reider, President Flandreau Santee Sioux Tribe of South Dakota 603 West Broad Avenue P.O. Box 238 Flandreau, SD 57208
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear President Reider:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
A. Reider 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Flandreau Santee Sioux Tribe of South Dakota under NHPA.
Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
A. Reider 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Garrie-Kills-A-Hundred, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Edgar B. Kent, Jr., Chairman Iowa Tribe of Oklahoma 335588 E. 750 Rd.
Perkins, OK 74059
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Kent:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
E. Kent 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Iowa Tribe of Oklahoma under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
E. Kent 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Phillip Cravatt, NAGPRA Contact
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Ned Daniels Jr., Chairman Forest County Potawatomi Community 5416 Everybody's Rd.
P.O. Box 340 Crandon, WI 54520M
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Daniels:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
N. Daniels 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Forest County Potawatomi Community under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
N. Daniels 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Michael LaRonge, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Kenneth Meshigaud, Chairperson Hannahville Indian Community N14911 Hannahville B-1 Rd.
Wilson MI 49896
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairperson Meshigaud:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
K. Meshigaud 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Hannahville Indian Community under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
K. Meshigaud 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Earl Meshigaud Tribal Cultural Representative
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Marlon White Eagle, President Ho-Chunk Nation of Wisconsin P.O. Box 667 W9814 Airport Road Black River Falls, WI 54615
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear President White Eagle:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
M. White Eagle 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Ho-Chunk Nation of Wisconsin under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m., as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
M. White Eagle 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. William Quackenbush, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Justin F. Wood, Principal Chief Sac and Fox Nation Administration Building 920883 S. Hwy 99, Bldg. A Stroud, OK 74079
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Principal Chief Wood:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
J. Wood 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Sac and Fox Nation under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs
[see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
J. Wood 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Robert Larsen, President Lower Sioux Indian Community 39527 Res. Highway 1 P.O. Box 308 Morton, MN 56270
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear President Larsen:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
R. Larsen 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Lower Sioux Indian Community under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
R. Larsen 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Cheyanne St. John, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Joseph Zeke Rupnick, Chairperson Prairie Band of Potawatomi Nation 16281 Q Road Mayetta, KS 66509
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairperson Rupnick:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
J. Rupnik 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Prairie Band of Potawatomi Nation under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
J. Rupnick 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Ms. Shelley Buck, President Prairie Island Indian Community 5636 Sturgeon Lake Road Welch, MN 55089
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear President Buck:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
S. Buck 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Prairie Island Indian Community under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
S. Buck 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Noah White, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Roger Trudell, Tribal Chairman Santee Sioux Nation 108 Spirit Lake Ave. W.
Niobrara, NE 68760
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Trudell:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
R. Trudell 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Santee Sioux Nation under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
R. Trudell 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Rick Thomas, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Donavan White, Tribal Chairman Sisseton-Wahpeton Oyate of the Lake Traverse Reservation 12554 BIA Hwy 711 P.O. Box 509 Agency Village, SD 57262
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Tribal Chairman White:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
D. White 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Sisseton-Wahpeton Oyate of the Lake Traverse Reservation under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
D. White 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Ms. Dianne Desroisiers, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Ms. Peggy Cavanaugh, Tribal Chairperson Spirit Lake Tribe 816 3rd Avenue North P.O. Box 359 Fort Totten, ND 58335
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Tribal Chairperson Cavanaugh:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
P. Cavanaugh 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Spirit Lake Tribe under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs
[see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
P. Cavanaugh 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Dr. Erich Longie, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Kevin Jensvold, Chairman Upper Sioux Community 5722 Travers Lane P.O. Box 147 Granite Falls, MN 56241
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Jensvold:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
K. Jensvold 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Upper Sioux Community under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
K. Jensvold 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Ms. Samantha Odegard, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Craig Harper, Chief Peoria Tribe of Indians of Oklahoma 118 S. Eight Tribes Trail P.O. Box 1527 Miami, OK 74355
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chief Harper:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
C. Harper 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Peoria Tribe of Indians of Oklahoma under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
C. Harper 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Logan Pappenfort, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Coly Brown, Chairman Winnebago Tribe of Nebraska 100 Bluff Street P.O. Box 687 Winnebago, NE 68071
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Brown:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
C. Brown 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Winnebago Tribe of Nebraska under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
C. Brown 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Randy Teboe, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Andrew "Andy" Werk Jr., President Fort Belknap Indian Community of the Fort Belknap Reservation of Montana 656 Agency Main Street RR 1, P.O. Box 66 Harlem, MT 59526
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear President Werk:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
A. Werk 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Fort Belknap Indian Community of the Fort Belknap Reservation of Montana under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
A. Werk 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Mr. Michael J. Black Wolf, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Joseph Wildcat, Sr., President Lac du Flambeau Band of Lake Superior Chippewa Indians 418 Little Pines Road P.O. Box 67 Lac du Flambeau, WI 54538
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear President Wildcat:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
J. Wildcat 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Lac du Flambeau Band of Lake Superior Chippewa Indians under NHPA.
Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
J. Wildcat 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Ms. Melinda Young, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Ms. Regina Gasco Bentley, Chairman Little Traverse Bay Bands of Odawa Indians 7500 Odawa Circle Harbor Springs, MI 49740
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chairman Bentley:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
R. Bentley 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Little Traverse Bay Bands of Odawa Indians under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
R. Bentley 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Ms. Melissa Wiatrolik, THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Douglas Lankford, Chief Miami Tribe of Oklahoma 3410 P St. NW P.O. Box 1326 Miami, OK 74355
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chief Lankford:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
D. Lankford 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Miami Tribe of Oklahoma under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
D. Lankford 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Ms. Diane Hunter, Acting THPO
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Geoffrey Standing Bear, Chief Osage Nation 627 Grandview Pawhuska, OK 74056
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Chief Standing Bear:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013-2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final environmental impact statement. Therefore, the NRC will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
D. Sanding Bear 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. The purpose of this letter is to initiate Section 106 consultation with the Osage Nation under NHPA. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs
[see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
D. Standing Bear 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site cc w/encls:
Listserv Dr. Andrea A. Hunter, THPO
ML19325E112 *via email OFFICE NMSS/REFS NMSS/REFS NMSS/REFS NMSS/REFS NMSS/REFS NAME AWalker-Smith RHoffman *NMartinez JDavis RElliott DATE 11/22/2019 11/22/2019 11/22/2019 11/22/2019 11/27/2019
- Area Map, 6-mile radius : Aerial View of the SHINE Site